9BD0 image
Deposition Date 2024-04-10
Release Date 2024-05-29
Last Version Date 2024-07-03
Entry Detail
PDB ID:
9BD0
Keywords:
Title:
Solution Structure of a Disulfide Insertion Mutant of S. aureus SPIN
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Conformers Calculated:
300
Conformers Submitted:
20
Selection Criteria:
target function
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Myeloperoxidase inhibitor SPIN
Mutations:V31C, D41C
Chain IDs:A
Chain Length:78
Number of Molecules:1
Biological Source:Staphylococcus aureus
Ligand Molecules
Primary Citation
Staphylococcal peroxidase inhibitor (SPIN): Investigation of the inhibitory N-terminal domain via a stabilizing disulfide insertion.
Arch.Biochem.Biophys. 758 110060 110060 (2024)
PMID: 38880318 DOI: 10.1016/j.abb.2024.110060

Abstact

Staphylococcus aureus secretes an array of small proteins that inhibit key enzyme-catalyzed reactions necessary for proper function of the human innate immune system. Among these, the Staphylococcal Peroxidase Inhibitor, SPIN, blocks the activity of myeloperoxidase (MPO) and thereby disrupts the HOCl-generating system of neutrophils. Previous studies on S. aureus SPIN have shown that it relies on a C-terminal α-helical bundle domain to mediate initial binding to MPO, but requires a disordered N-terminal region to fold into a β-hairpin conformation to inhibit MPO activity. To further investigate the structure/function relationship of SPIN, we introduced two cysteine residues into its N-terminal region to trap SPIN in its MPO-bound conformation and characterized the modified protein, which we refer to here as SPIN-CYS. Although control experiments confirmed the presence of the disulfide bond in SPIN-CYS, solution structure determination revealed that the N-terminal region of SPIN-CYS adopted a physically constrained series of lariat-like structures rather than a well-defined β-hairpin. Nevertheless, SPIN-CYS exhibited a gain in inhibitory potency against human MPO when compared to wild-type SPIN. This gain of function persisted even in the presence of deleterious mutations within the C-terminal α-helical bundle domain. Surface plasmon resonance studies showed that the gain in potency arose through an increase in apparent affinity of SPIN-CYS for MPO, which was driven primarily by an increased association rate with MPO when compared to wild-type SPIN. Together, this work provides new information on the coupled binding and folding events required to manifest biological activity of this unusual MPO inhibitor.

Legend

Protein

Chemical

Disease

Primary Citation of related structures